Biotechnology contract manufacturing is rapidly transforming, driven by innovations in life-saving therapeutics. CMOs enable pharmaceutical companies to focus on R&D by handling the manufacturing of
Author: Violet Rufus
Violet Rufus is a distinguished technology writer and fintech expert with a passion for exploring the intersection of finance and innovation. She holds a Master’s degree in Technology Management from the prestigious Quivira Institute, where she developed a strong foundation in emerging technologies and their applications in the financial sector. With over a decade of experience in the industry, Violet previously held a key position at Future Dynamics, where she analyzed market trends and contributed to cutting-edge fintech solutions. Her insightful articles and reports have been featured in numerous leading publications, helping to demystify complex technological advancements for a broader audience. Through her work, Violet continues to inspire professionals and laypersons alike to embrace the rapidly evolving landscape of financial technology.
The Tension Unfolding in Europe’s Biotech Arena: Balancing Innovation and Biosecurity
Europe’s biotech sector, controlling 12% of the global market, is focused on innovation and biosecurity excellence. Key discussions highlight the need to balance groundbreaking biotech
Breakthrough Partnership: Disperazol Pharma Takes Bold Steps Against Global Antibiotic Resistance
Disperazol Pharma partners with AMR Industry Alliance to combat antimicrobial resistance (AMR). Over 1.27 million deaths occur yearly due to AMR-related infections, highlighting the urgent
Major Shift in USDA Guidelines! New Rules for Genetically Engineered Organisms
USDA Retracts 2020 Rules on Genetically Modified Organisms In a surprising move, the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) revealed